Spontaneous pneumomediastinum: a surrogate of P-SILI in critically ill COVID-19 patients.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
12 11 2022
Historique:
received: 06 07 2022
accepted: 02 11 2022
entrez: 12 11 2022
pubmed: 13 11 2022
medline: 16 11 2022
Statut: epublish

Résumé

Spontaneous pneumomediastinum (SP) has been described early during the COVID-19 pandemic in large series of patients with severe pneumonia, but most patients were receiving invasive mechanical ventilation (IMV) at the time of SP diagnosis. In this retrospective multicenter observational study, we aimed at describing the prevalence and outcomes of SP during severe COVID-19 with pneumonia before any IMV, to rule out mechanisms induced by IMV in the development of pneumomediastinum.Among 549 patients, 21 patients (4%) developed a SP while receiving non-invasive respiratory support, after a median of 6 days [4-12] from ICU admission. The proportion of patients requiring IMV was similar. However, the time to tracheal intubation was longer in patients with SP (6 days [5-13] vs. 2 days [1-4]; P = 0.00002), with a higher first-line use of non-invasive ventilation (n = 11; 52% vs. n = 150; 28%; P = 0.02). The 21 patients who developed a SP had persisting signs of severe lung disease and respiratory failure with lower ROX index between ICU admission and occurrence of SP (3.94 [3.15-5.55] at admission vs. 3.25 [2.73-4.02] the day preceding SP; P = 0.1), which may underline potential indirect signals of Patient-self inflicted lung injury (P-SILI).In this series of critically ill COVID-19 patients, the prevalence of SP without IMV was not uncommon, affecting 4% of patients. They received more often vasopressors and had a longer ICU length of stay, as compared with their counterparts. One pathophysiological mechanism may potentially be carried out by P-SILI related to a prolonged respiratory failure, as underlined by a delayed use of IMV and the evolution of the ROX index between ICU admission and the day preceding SP.

Identifiants

pubmed: 36371306
doi: 10.1186/s13054-022-04228-1
pii: 10.1186/s13054-022-04228-1
pmc: PMC9652578
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

350

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

Abolnik I, Lossos IS, Breuer R. Spontaneous pneumomediastinum. A report of 25 cases. Chest 1991;100:93–95.
Anzueto A, et al. Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients. Intensive Care Med. 2004;30:612–9.
doi: 10.1007/s00134-004-2187-7
Revel M-P, et al. COVID-19 patients and the radiology department—advice from the European society of radiology (ESR) and the European society of thoracic imaging (ESTI). Eur Radiol. 2020;30:4903–9.
doi: 10.1007/s00330-020-06865-y
Contou D, et al. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: No prognostic improvement during the second wave? Crit Care. 2021;25:3.
doi: 10.1186/s13054-020-03449-6
Chu CM, et al. Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome. Eur Respir J. 2004;23:802–4.
doi: 10.1183/09031936.04.00096404
Peiris JSM, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–72.
doi: 10.1016/S0140-6736(03)13412-5
McGuinness G, et al. Increased Incidence of Barotrauma in Patients with COVID-19 on invasive mechanical ventilation. Radiology. 2020;297:E252–62.
doi: 10.1148/radiol.2020202352
Bonato M, et al. Pneumothorax and/or pneumomediastinum worsens the prognosis of COVID-19 patients with severe acute respiratory failure: a multicenter retrospective case-control study in the north–east of Italy. J Clin Med. 2021;10:4835.
doi: 10.3390/jcm10214835
Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med. 2017;195:438–42.
doi: 10.1164/rccm.201605-1081CP
Carteaux G, et al. Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume. Crit Care Med. 2016;44:282–90.
doi: 10.1097/CCM.0000000000001379
Grieco DL, et al. Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA. 2021;325:1731–43.
doi: 10.1001/jama.2021.4682
Ehrmann S, et al. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021;9:1387–95.
doi: 10.1016/S2213-2600(21)00356-8
Carteaux G, et al. Patient-self inflicted lung injury: a practical review. J Clin Med. 2021;10:2738.
doi: 10.3390/jcm10122738
Coppola S, et al. Role of total lung stress on the progression of early COVID-19 pneumonia. Intensive Care Med. 2021;47:1130–9.
doi: 10.1007/s00134-021-06519-7
Tonelli R, et al. Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19: a matched control study. Am J Respir Crit Care Med. 2021;204:725–8.
doi: 10.1164/rccm.202104-1029LE
Tonelli R et al. Early inspiratory effort assessment by esophageal manometry predicts noninvasive ventilation outcome in de novo respiratory failure. A pilot study. Am J Respir Crit Care Med. (2020);202:558–567.
Sihoe ADL, et al. Severe acute respiratory syndrome complicated by spontaneous pneumothorax. Chest. 2004;125:2345–51.
doi: 10.1378/chest.125.6.2345
Sekhon MS, Thiara S, Kanji HD, Ronco JJ. Spontaneous pneumomediastinum in COVID-19: The Macklin effect? Am J Respir Crit Care Med. 2021;204:989–90.
doi: 10.1164/rccm.202105-1179IM

Auteurs

Alexandre Elabbadi (A)

Assistance Publique - Hôpitaux de Paris, Service de Médecine Intensive Réanimation, Hôpital Tenon, APHP, Sorbonne Université, 4 Rue de la Chine, 75020, Paris, France. alexandre.elabbadi@aphp.fr.

Tomas Urbina (T)

Assistance Publique - Hôpitaux de Paris, Service de Médecine Intensive Réanimation, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.

Enora Berti (E)

Assistance Publique - Hôpitaux de Paris, DMU Médecine, Service de Médecine Intensive Réanimation, Hôpital Henri Mondor, Hôpitaux Universitaires Henri Mondor, Créteil, France.

Damien Contou (D)

Service de Réanimation Polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France.

Gaëtan Plantefève (G)

Service de Réanimation Polyvalente, Centre Hospitalier Victor Dupouy, Argenteuil, France.

Quintana Soulier (Q)

Assistance Publique - Hôpitaux de Paris, Service de Médecine Intensive Réanimation, Hôpital Saint-Antoine, Sorbonne Université, Paris, France.

Audrey Milon (A)

Assistance Publique - Hôpitaux de Paris, Service de Radiologie, Hôpital Tenon, Sorbonne Université, Paris, France.

Guillaume Carteaux (G)

Assistance Publique - Hôpitaux de Paris, DMU Médecine, Service de Médecine Intensive Réanimation, Hôpital Henri Mondor, Hôpitaux Universitaires Henri Mondor, Créteil, France.

Guillaume Voiriot (G)

Assistance Publique - Hôpitaux de Paris, Service de Médecine Intensive Réanimation, Hôpital Tenon, APHP, Sorbonne Université, 4 Rue de la Chine, 75020, Paris, France.

Muriel Fartoukh (M)

Assistance Publique - Hôpitaux de Paris, Service de Médecine Intensive Réanimation, Hôpital Tenon, APHP, Sorbonne Université, 4 Rue de la Chine, 75020, Paris, France.

Aude Gibelin (A)

Assistance Publique - Hôpitaux de Paris, Service de Médecine Intensive Réanimation, Hôpital Tenon, APHP, Sorbonne Université, 4 Rue de la Chine, 75020, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH